Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.
Trials
; 23(1): 480, 2022 Jun 10.
Article
in En
| MEDLINE
| ID: mdl-35689272
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rifampin
/
Diabetes Mellitus, Type 2
/
Latent Tuberculosis
/
Isoniazid
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Qualitative_research
/
Risk_factors_studies
Limits:
Adult
/
Humans
Country/Region as subject:
Africa
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2022
Type:
Article
Affiliation country:
Tanzania